<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Wolverine — Peptide Editorial</title><description>Science journalism on peptide therapy. Cited, dialectic, not medical advice.</description><link>https://wolverine.health/</link><language>en-us</language><item><title>BPC-157&apos;s PCAC Recommendation Arrived Before Its Evidence Did</title><link>https://wolverine.health/articles/what-happens-after-pcac/</link><guid isPermaLink="true">https://wolverine.health/articles/what-happens-after-pcac/</guid><description>BPC-157 just got a federal advisory committee&apos;s recommendation, months after coming off a safety watchlist. Here&apos;s what actually happened in between, and what the recommendation does and doesn&apos;t mean for the vial in your fridge.</description><pubDate>Thu, 10 Sep 2026 06:39:03 GMT</pubDate><content:encoded/></item><item><title>Thymosin Alpha-1 Corrects a Measurable Immune Deficit. Yours Might Not Have One Yet.</title><link>https://wolverine.health/articles/thymosin-alpha-1-immune/</link><guid isPermaLink="true">https://wolverine.health/articles/thymosin-alpha-1-immune/</guid><description>Thymosin Alpha-1 is a real, internationally approved drug for a documented immune deficit, not a peptide-store rumour. Whether that same signal holds for a healthy 50-year-old with no diagnosis is the part nobody has actually tested.</description><pubDate>Wed, 09 Sep 2026 07:28:25 GMT</pubDate><content:encoded/></item><item><title>Semax: A Real Peptide With a Clinical Record the West Can&apos;t Audit</title><link>https://wolverine.health/articles/semax-cognitive/</link><guid isPermaLink="true">https://wolverine.health/articles/semax-cognitive/</guid><description>Semax has a documented mechanism and a quarter-century of authorised use in Russia. Whether either of those things adds up to evidence a Western reader can actually check is a separate, unresolved question.</description><pubDate>Sun, 06 Sep 2026 11:46:13 GMT</pubDate><content:encoded/></item><item><title>AOD-9604: The Growth Hormone Fragment That Failed Its Own Trial</title><link>https://wolverine.health/articles/aod-9604-fat-loss/</link><guid isPermaLink="true">https://wolverine.health/articles/aod-9604-fat-loss/</guid><description>AOD-9604 isolates the fat-burning piece of growth hormone from the piece that makes you grow. Whether that clean design actually worked in a human body, and what regulators decided about it, is the open question here.</description><pubDate>Sat, 05 Sep 2026 18:43:57 GMT</pubDate><content:encoded/></item><item><title>Epithalon and the Telomere Question Nobody Has Answered</title><link>https://wolverine.health/articles/epithalon-longevity/</link><guid isPermaLink="true">https://wolverine.health/articles/epithalon-longevity/</guid><description>One Soviet-era mouse study says a four-amino-acid peptide can lengthen the cap on your DNA. Twenty-five years later, nobody outside that lab has checked whether it&apos;s real, or whether it means anything for how long you live.</description><pubDate>Fri, 04 Sep 2026 23:32:36 GMT</pubDate><content:encoded/></item><item><title>GHK-Cu Falls With Age. The One Human Skin Trial Found Nothing.</title><link>https://wolverine.health/articles/ghk-cu-skin-aging/</link><guid isPermaLink="true">https://wolverine.health/articles/ghk-cu-skin-aging/</guid><description>GHK-Cu drops sharply with age and does striking things to cells in a dish. Whether any of that survives contact with actual human skin is a separate, unresolved question.</description><pubDate>Fri, 04 Sep 2026 22:59:38 GMT</pubDate><content:encoded/></item><item><title>TB-500 and Tendon Repair: The Actin Science Is Real. The Human Data Isn&apos;t.</title><link>https://wolverine.health/articles/tb-500-tendon-repair/</link><guid isPermaLink="true">https://wolverine.health/articles/tb-500-tendon-repair/</guid><description>Thymosin beta-4&apos;s actin-grabbing mechanism is well mapped in the lab. Whether an injected synthetic version actually speeds tendon repair in a human body is a question the published research has never actually asked.</description><pubDate>Fri, 04 Sep 2026 22:48:03 GMT</pubDate><content:encoded/></item><item><title>BPC-157 and the Missing Human Trial: What the Animal Data Actually Proves</title><link>https://wolverine.health/articles/bpc-157-injury-recovery/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157-injury-recovery/</guid><description>BPC-157&apos;s animal and anecdotal record for tendon and gut repair is unusually consistent. Whether that holds up in a human body is a question no completed trial has answered yet.</description><pubDate>Fri, 04 Sep 2026 21:42:43 GMT</pubDate><content:encoded/></item><item><title>PCAC: The FDA Committee Deciding Whether BPC-157 Stays Legal to Compound</title><link>https://wolverine.health/articles/what-is-pcac/</link><guid isPermaLink="true">https://wolverine.health/articles/what-is-pcac/</guid><description>PCAC decided something about BPC-157 in July 2026, and most of the peptide world still can&apos;t say what, or what it doesn&apos;t mean.</description><pubDate>Fri, 04 Sep 2026 20:42:35 GMT</pubDate><content:encoded/></item><item><title>BPC-157&apos;s Animal Data Is Real. Its Human Data Is Almost Nonexistent, Until Now.</title><link>https://wolverine.health/articles/bpc-157/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157/</guid><description>BPC-157&apos;s rat data has held up for decades. Whether that mechanism does anything for the actual human joint you&apos;re injecting it into is a question a brand-new Phase 2 trial has only just started to answer.</description><pubDate>Tue, 01 Sep 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>GHK-Cu&apos;s Mechanism Is Real. Its Human Trial Record Isn&apos;t There Yet.</title><link>https://wolverine.health/articles/ghk-cu/</link><guid isPermaLink="true">https://wolverine.health/articles/ghk-cu/</guid><description>GHK-Cu has some of the cleanest cell-biology data in peptide science: gene remodelling, wound signalling, antioxidant activity. Whether any of that survives the jump from a dish to a human body is still an open question.</description><pubDate>Tue, 01 Sep 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>KPV: The Alpha-MSH Fragment With Real Mouse Data and Zero Human Trials</title><link>https://wolverine.health/articles/kpv/</link><guid isPermaLink="true">https://wolverine.health/articles/kpv/</guid><description>KPV&apos;s rodent gut and inflammation data is genuinely coherent. Whether any of that biology survives contact with a human body has never been tested.</description><pubDate>Tue, 01 Sep 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>TB-500 Is Sold as a Tendon-Repair Peptide. The Research Behind It Isn&apos;t.</title><link>https://wolverine.health/articles/tb-500/</link><guid isPermaLink="true">https://wolverine.health/articles/tb-500/</guid><description>TB-500&apos;s reputation rides on real experiments with thymosin beta-4 in animals. Whether that evidence covers the molecule people are actually injecting is a separate, open question.</description><pubDate>Tue, 01 Sep 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>The BPC-157 Route Debate Has No Human Bioavailability Data Behind It</title><link>https://wolverine.health/articles/bpc-157-oral-vs-injectable-bioavailability/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157-oral-vs-injectable-bioavailability/</guid><description>The oral-versus-injectable debate for BPC-157 gets argued with total confidence online. The actual bioavailability data behind those arguments, in either direction, is worth checking before you pick a side.</description><pubDate>Sun, 30 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>KPV: A Real Anti-Inflammatory Signal, an Unproven Skin Case</title><link>https://wolverine.health/articles/kpv-skin-barrier-topical-application/</link><guid isPermaLink="true">https://wolverine.health/articles/kpv-skin-barrier-topical-application/</guid><description>KPV&apos;s gut and immune-cell science is solid. Whether that translates into a working skin-barrier product is the open question nobody&apos;s tested yet.</description><pubDate>Fri, 28 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>TB-500 Doesn&apos;t Suppress Inflammation. The Evidence Says It Redirects It.</title><link>https://wolverine.health/articles/tb-500-wound-healing-inflammation-phase/</link><guid isPermaLink="true">https://wolverine.health/articles/tb-500-wound-healing-inflammation-phase/</guid><description>TB-500 gets sold as an anti-inflammatory peptide. The animal studies behind that claim used a different molecule than the one in most vials, and nobody has tested whether timing during the wound&apos;s inflammatory window changes the outcome.</description><pubDate>Fri, 28 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>GHK-Cu and the Ten Weeks Nobody Has Actually Tested</title><link>https://wolverine.health/articles/ghk-cu-wound-remodeling-collagen-signaling/</link><guid isPermaLink="true">https://wolverine.health/articles/ghk-cu-wound-remodeling-collagen-signaling/</guid><description>Every study on GHK-Cu&apos;s wound-healing chemistry stops at the fibroblast dish. What happens once a wound closes, in the weeks that actually build a scar, is a different, mostly untested question.</description><pubDate>Fri, 28 Aug 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>KPV&apos;s MC1R Story: A Real Anti-Inflammatory Signal, Zero Human Data</title><link>https://wolverine.health/articles/kpv-melanocortin-immune-mechanism/</link><guid isPermaLink="true">https://wolverine.health/articles/kpv-melanocortin-immune-mechanism/</guid><description>KPV, a three-amino-acid fragment of alpha-MSH, shows a consistent anti-inflammatory signal in cells and mice. No human trial has tested whether that mechanism, or its proposed MC1R selectivity, works the same way in a person.</description><pubDate>Wed, 26 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>TB-500&apos;s Real Paper Trail Is About Hearts, Not Tendons</title><link>https://wolverine.health/articles/tb-500-cardiovascular-angiogenesis-mechanism/</link><guid isPermaLink="true">https://wolverine.health/articles/tb-500-cardiovascular-angiogenesis-mechanism/</guid><description>TB-500&apos;s reputation rests on tendon anecdote, but the peer-reviewed record on thymosin beta-4 is overwhelmingly cardiac: actin sequestration, epicardial progenitor signaling, coronary angiogenesis. No human cardiac trial exists, and grey-market TB-500 may not match the molecule studied.</description><pubDate>Wed, 26 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>GHK-Cu and Hair Loss: A Real Mechanism, No Human Trial Behind It</title><link>https://wolverine.health/articles/ghk-cu-hair-loss-follicle-biology/</link><guid isPermaLink="true">https://wolverine.health/articles/ghk-cu-hair-loss-follicle-biology/</guid><description>GHK-Cu has a plausible, multi-pathway mechanism for hair-follicle regeneration, but almost all the evidence is in vitro and animal-model work from the 1990s and 2000s. No human trial has tested it in hair, and the sole human RCT in skin found no effect.</description><pubDate>Wed, 26 Aug 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>KPV&apos;s Gut-Inflammation Case Rests on One Mouse Trial</title><link>https://wolverine.health/articles/kpv-gut-inflammation/</link><guid isPermaLink="true">https://wolverine.health/articles/kpv-gut-inflammation/</guid><description>KPV, a three-amino-acid fragment of alpha-MSH, quiets inflammatory signalling in cell studies and a single mouse colitis trial. Whether it reaches inflamed human gut tissue, and works there, has never been tested.</description><pubDate>Sat, 22 Aug 2026 14:00:00 GMT</pubDate><content:encoded/></item><item><title>PCAC Recommended Both BPC-157 and TB-500. That&apos;s Not a Stacking Protocol.</title><link>https://wolverine.health/articles/pcac-recommended-bpc-157-and-tb-500/</link><guid isPermaLink="true">https://wolverine.health/articles/pcac-recommended-bpc-157-and-tb-500/</guid><description>PCAC voted to recommend BPC-157 and TB-500 for the FDA&apos;s 503A compounding list, each on its own 8-6 vote. Here&apos;s what the human trial record for each peptide shows, and where the case for stacking them turns from evidence into theory.</description><pubDate>Sat, 22 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>The Injury-Recovery Peptide Stack: What the Evidence Actually Supports, Compound by Compound</title><link>https://wolverine.health/articles/injury-recovery-peptide-overview/</link><guid isPermaLink="true">https://wolverine.health/articles/injury-recovery-peptide-overview/</guid><description>BPC-157, TB-500, and GHK-Cu are sold as one interchangeable injury-recovery stack, but their human evidence ranges from a real Phase 2 trial to a molecular identity gap to a null placebo-controlled result. Each is graded on its own record, not the group&apos;s pitch.</description><pubDate>Fri, 21 Aug 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>The Wolverine Stack: what BPC-157 and TB-500 together could do</title><link>https://wolverine.health/articles/bpc-157-vs-tb-500-the-wolverine-stack/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157-vs-tb-500-the-wolverine-stack/</guid><description>The Wolverine Stack pairs BPC-157 and TB-500 into one repair protocol — on paper a genuinely good idea: two peptides doing two different repair jobs. Here&apos;s what the pairing is meant to do for you, why the biology is exciting, and the one thing nobody has ever tested — the two of them run together.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>The peptide the FDA already voted against</title><link>https://wolverine.health/articles/the-peptide-the-fda-already-voted-against/</link><guid isPermaLink="true">https://wolverine.health/articles/the-peptide-the-fda-already-voted-against/</guid><description>Everyone heard &quot;peptides are coming back.&quot; Almost nobody heard that the FDA already sat down with some of the most-stacked ones and voted no. Here&apos;s which, when, and what a July 2026 yes would actually buy you.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>What BPC-157 actually does: the plain answer on the repair peptide</title><link>https://wolverine.health/articles/what-bpc-157-actually-does/</link><guid isPermaLink="true">https://wolverine.health/articles/what-bpc-157-actually-does/</guid><description>BPC-157 is the repair peptide half the gym is talking about. Strip out the forum noise and the answer is simple: in animals it speeds healing by growing new blood supply into injured tissue. Here is what that could mean for you, how far the human proof goes, and what the FDA is about to review.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>What GHK-Cu actually does — the plain answer</title><link>https://wolverine.health/articles/what-ghk-cu-actually-does/</link><guid isPermaLink="true">https://wolverine.health/articles/what-ghk-cu-actually-does/</guid><description>GHK-Cu is a copper-carrying peptide your body makes to repair itself, and makes less of as you age. Here&apos;s the plain-English answer: what it could do for you, why the biology is exciting, how far the human proof goes — and where the injectable form sits in the FDA&apos;s next compounding review.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Peptide access by US state: why the regulatory patchwork right now is real</title><link>https://wolverine.health/articles/state-telehealth-peptide-variation/</link><guid isPermaLink="true">https://wolverine.health/articles/state-telehealth-peptide-variation/</guid><description>The federal compounding framework applies the same way in every state. The state pharmacy boards do not. The result is a real state-by-state patchwork that decides whether a telehealth prescription for a compounded peptide is actually fillable where you live.</description><pubDate>Fri, 05 Jun 2026 19:45:00 GMT</pubDate><content:encoded/></item><item><title>What RFK Jr.&apos;s February 2026 announcement actually said about peptides</title><link>https://wolverine.health/articles/rfk-peptides-announcement/</link><guid isPermaLink="true">https://wolverine.health/articles/rfk-peptides-announcement/</guid><description>The &quot;announcement&quot; was a Joe Rogan appearance, not a Federal Register notice. The wellness scene heard one thing. The actual signal was narrower, and the rulemaking that turns it into access is still more than a year away.</description><pubDate>Fri, 05 Jun 2026 19:30:00 GMT</pubDate><content:encoded/></item><item><title>503B outsourcing pharmacies and compounded peptides: the regulatory gap that still matters</title><link>https://wolverine.health/articles/fda-503b-outsourcing-peptides/</link><guid isPermaLink="true">https://wolverine.health/articles/fda-503b-outsourcing-peptides/</guid><description>Section 503B outsourcing facilities are the higher-volume, FDA-inspected cousin of the corner compounding pharmacy. The 503B Bulks List is its own regulatory pipeline — and it changes what an actual peptide supply chain looks like when one opens.</description><pubDate>Fri, 05 Jun 2026 14:30:00 GMT</pubDate><content:encoded/></item><item><title>The PCAC review happened July 23–24, 2026. Here is what that means for peptide access.</title><link>https://wolverine.health/articles/pcac-review-july-2026/</link><guid isPermaLink="true">https://wolverine.health/articles/pcac-review-july-2026/</guid><description>Two days at FDA&apos;s White Oak campus decided which of seven peptides US compounding pharmacies may eventually dispense by prescription. The recommendation is not an approval, the docket is not all the peptides, and the framing the forums used going in was mostly wrong.</description><pubDate>Fri, 05 Jun 2026 14:00:00 GMT</pubDate><content:encoded/></item><item><title>Anti-inflammatory peptides: what calming chronic inflammation could do for you</title><link>https://wolverine.health/articles/anti-inflammatory-peptides/</link><guid isPermaLink="true">https://wolverine.health/articles/anti-inflammatory-peptides/</guid><description>Chronic, low-grade inflammation tracks with slower recovery, stiff joints, and how fast you age. Three peptides under FDA review — KPV, BPC-157, and GHK-Cu — each turn it down from a different direction. Here is what that could mean for you, and how far the human proof actually goes.</description><pubDate>Tue, 02 Jun 2026 13:00:00 GMT</pubDate><content:encoded/></item><item><title>AOD-9604 and adiponectin: the fat-loss signal that skips growth hormone</title><link>https://wolverine.health/articles/adiponectin-aod-9604/</link><guid isPermaLink="true">https://wolverine.health/articles/adiponectin-aod-9604/</guid><description>Most fat-loss peptides work by turning up your whole growth-hormone system and hoping the fat follows. AOD-9604 skips that and talks to the fat cell directly — a cleaner idea. Here is how the mechanism works, why your fat is a hormone-producing organ, and how far the human proof actually goes.</description><pubDate>Tue, 02 Jun 2026 12:30:00 GMT</pubDate><content:encoded/></item><item><title>The thymus: the vanishing organ behind your ageing immune system</title><link>https://wolverine.health/articles/thymosin-thymus-immune/</link><guid isPermaLink="true">https://wolverine.health/articles/thymosin-thymus-immune/</guid><description>The thymus trained every immune cell you own, then started shrinking in your teens. Its slow fade is a big reason immunity gets weaker with age — and the reason a family of thymus-signal peptides is worth understanding. Here is the biology, in plain language.</description><pubDate>Tue, 02 Jun 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>How to read a peptide study: five questions that tell the real thing from the sell</title><link>https://wolverine.health/articles/how-to-read-a-peptide-study/</link><guid isPermaLink="true">https://wolverine.health/articles/how-to-read-a-peptide-study/</guid><description>You don&apos;t need a biology degree to judge peptide evidence yourself. You need five questions. Ask them of any study a seller quotes at you and the real signal pulls away from the sell — and the whole field gets more exciting once you can tell which promises have something under them.</description><pubDate>Tue, 02 Jun 2026 09:30:00 GMT</pubDate><content:encoded/></item><item><title>Collagen-synthesis peptides: what a better repair signal could do for you</title><link>https://wolverine.health/articles/collagen-synthesis-peptides/</link><guid isPermaLink="true">https://wolverine.health/articles/collagen-synthesis-peptides/</guid><description>Collagen is the scaffolding under your skin, tendons, and joints — and three peptides now in front of the FDA each lean on how your body builds it. Here is what that could mean for repair and ageing, why the biology is genuinely exciting, and how far the human proof actually goes.</description><pubDate>Tue, 02 Jun 2026 09:00:00 GMT</pubDate><content:encoded/></item><item><title>Peptide bioavailability: why your peptide is a needle, not a pill</title><link>https://wolverine.health/articles/peptide-bioavailability/</link><guid isPermaLink="true">https://wolverine.health/articles/peptide-bioavailability/</guid><description>Most peptides come as a vial and a needle for one reason — swallow them and your gut destroys them before they can work. Understanding how a peptide actually gets into your body is the single lens that tells you whether a product can work at all. Here is how it works, in plain English.</description><pubDate>Mon, 01 Jun 2026 23:00:00 GMT</pubDate><content:encoded/></item><item><title>Your stress switch: how the HPA axis works, and where Selank and Semax reach into it</title><link>https://wolverine.health/articles/hpa-axis-selank-semax/</link><guid isPermaLink="true">https://wolverine.health/articles/hpa-axis-selank-semax/</guid><description>Your body has a switch for stress — it should flip on under load and off when it passes. When it stops flipping off, you get the wired-and-foggy version most men know. Here is how that switch works, and how two Russian peptides could help it behave.</description><pubDate>Mon, 01 Jun 2026 22:30:00 GMT</pubDate><content:encoded/></item><item><title>Copper peptides: why GHK-Cu is not just a skincare trend</title><link>https://wolverine.health/articles/copper-peptide-biology/</link><guid isPermaLink="true">https://wolverine.health/articles/copper-peptide-biology/</guid><description>Copper is a metal your body repairs itself with — but too reactive to carry loose, so it travels clipped to a small peptide. That&apos;s a copper peptide, like GHK-Cu. Here&apos;s why the biology is exciting, how far the human proof goes, and where the injectable sits in the FDA&apos;s next compounding review.</description><pubDate>Mon, 01 Jun 2026 22:00:00 GMT</pubDate><content:encoded/></item><item><title>Telomeres, explained: the countdown inside your cells — and why longevity science keeps circling it</title><link>https://wolverine.health/articles/telomere-biology-basics/</link><guid isPermaLink="true">https://wolverine.health/articles/telomere-biology-basics/</guid><description>Telomeres cap your chromosomes, and get shorter every time a cell divides. Reset that countdown and you&apos;d slow ageing itself — the longevity holy grail. Here&apos;s the real biology, what could move it, and why telomere-lengthening as anti-ageing is still unproven in humans.</description><pubDate>Mon, 01 Jun 2026 21:00:00 GMT</pubDate><content:encoded/></item><item><title>New blood vessels: the repair signal behind BPC-157, TB-500 and GHK-Cu</title><link>https://wolverine.health/articles/angiogenesis-peptides/</link><guid isPermaLink="true">https://wolverine.health/articles/angiogenesis-peptides/</guid><description>Repair runs on fresh plumbing — new blood vessels growing into damaged tissue. It&apos;s the mechanism three of the most-talked-about recovery peptides — BPC-157, TB-500 and GHK-Cu — are built on. Here&apos;s what that could mean for how you heal, and the one question the same biology always raises.</description><pubDate>Mon, 01 Jun 2026 20:30:00 GMT</pubDate><content:encoded/></item><item><title>Growth hormone secretagogues: the peptides that turn your own growth hormone back up</title><link>https://wolverine.health/articles/growth-hormone-secretagogues-explainer/</link><guid isPermaLink="true">https://wolverine.health/articles/growth-hormone-secretagogues-explainer/</guid><description>CJC-1295, ipamorelin, sermorelin, and tesamorelin share one job — getting your own pituitary to release more growth hormone, the repair-and-recovery signal that fades after your twenties. Here is the appeal, the two peptide families inside the class, and how far the human proof actually goes.</description><pubDate>Mon, 01 Jun 2026 20:00:00 GMT</pubDate><content:encoded/></item><item><title>MOTs-C vs Epitalon: two different bets on ageing slower</title><link>https://wolverine.health/articles/mots-c-vs-epithalon-longevity/</link><guid isPermaLink="true">https://wolverine.health/articles/mots-c-vs-epithalon-longevity/</guid><description>MOTs-C and Epitalon are two very different longevity bets — one on your metabolism, one on the clock inside your cells. Here is what each could do for you, which angle fits your goal, and how far the human proof goes on both.</description><pubDate>Mon, 01 Jun 2026 18:00:00 GMT</pubDate><content:encoded/></item><item><title>Mitochondrial-derived peptides: the signals your engines stop sending</title><link>https://wolverine.health/articles/mitochondrial-peptide-class/</link><guid isPermaLink="true">https://wolverine.health/articles/mitochondrial-peptide-class/</guid><description>Your mitochondria don&apos;t just make energy — they send hormone-like signals that tell the body how to run, and the supply fades with age. Mitochondrial-derived peptides are that family. Here&apos;s what the class could do, how far proof goes, and where its most-studied member sits in July&apos;s FDA review.</description><pubDate>Mon, 01 Jun 2026 17:30:00 GMT</pubDate><content:encoded/></item><item><title>How BPC-157 works: the blood-supply trick behind the repair</title><link>https://wolverine.health/articles/bpc-157-mechanism/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157-mechanism/</guid><description>BPC-157&apos;s reputation rests on one mechanism — it appears to build fresh blood supply into damaged tissue. Here is that mechanism in plain language, angiogenesis and nitric oxide made simple, what it could mean for recovery, how far the animal proof goes, and the FDA review set for July 2026.</description><pubDate>Mon, 01 Jun 2026 16:30:00 GMT</pubDate><content:encoded/></item><item><title>What is a peptide? The plain-language guide for starting from zero</title><link>https://wolverine.health/articles/what-is-a-peptide/</link><guid isPermaLink="true">https://wolverine.health/articles/what-is-a-peptide/</guid><description>Peptides are the short chains of amino acids your body already uses to send signals — repair this, burn that, grow here. Some are drugs you trust, like insulin. Others are early and genuinely exciting. Here is the plain map of what they are, what they might do for you, and where the science stands.</description><pubDate>Mon, 01 Jun 2026 15:00:00 GMT</pubDate><content:encoded/></item><item><title>BPC-157 vs GHK-Cu: which repair peptide fits which kind of healing</title><link>https://wolverine.health/articles/bpc-157-vs-ghk-cu-healing/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157-vs-ghk-cu-healing/</guid><description>BPC-157 and GHK-Cu both get sold as tissue-repair peptides, but they are tools for two different jobs — BPC-157 for deep tissue like tendon and gut, GHK-Cu for skin and surface. Here is what each could do for you, which goal each one fits, and how far the proof actually goes.</description><pubDate>Mon, 01 Jun 2026 14:00:00 GMT</pubDate><content:encoded/></item><item><title>Sermorelin vs tesamorelin: which growth-hormone peptide is the right tool for you</title><link>https://wolverine.health/articles/sermorelin-vs-tesamorelin/</link><guid isPermaLink="true">https://wolverine.health/articles/sermorelin-vs-tesamorelin/</guid><description>Sermorelin and tesamorelin both nudge your pituitary to make more growth hormone. One targets deep visceral fat with a real Phase 3 behind it; the other is the gentler GH-axis nudge with an FDA past. Here&apos;s which one fits which goal — and why one is still an approved drug and the other isn&apos;t.</description><pubDate>Mon, 01 Jun 2026 12:30:00 GMT</pubDate><content:encoded/></item><item><title>CJC-1295 vs ipamorelin: which growth-hormone peptide is the right tool for you?</title><link>https://wolverine.health/articles/cjc-1295-vs-ipamorelin/</link><guid isPermaLink="true">https://wolverine.health/articles/cjc-1295-vs-ipamorelin/</guid><description>CJC-1295 and ipamorelin are the internet&apos;s favourite growth-hormone pairing — but they do two different jobs. One raises your GH baseline for days from a single shot; the other fires a clean nightly pulse. Here&apos;s what each could do for you, which fits which goal, and why so many people run both.</description><pubDate>Mon, 01 Jun 2026 11:00:00 GMT</pubDate><content:encoded/></item><item><title>BPC-157 vs TB-500 for injury: which one is built for your tear</title><link>https://wolverine.health/articles/bpc-157-vs-tb-500-injury/</link><guid isPermaLink="true">https://wolverine.health/articles/bpc-157-vs-tb-500-injury/</guid><description>BPC-157 and TB-500 aren&apos;t two flavours of one recovery peptide — they&apos;re unrelated proteins aimed at different kinds of damage. Here is what each could actually do for you, which one fits which injury, and how far the human proof goes for both.</description><pubDate>Mon, 01 Jun 2026 09:41:15 GMT</pubDate><content:encoded/></item><item><title>Selank: calm without the benzodiazepine tax</title><link>https://wolverine.health/articles/selank-anxiety/</link><guid isPermaLink="true">https://wolverine.health/articles/selank-anxiety/</guid><description>Selank is Russia&apos;s attempt at an anxiety peptide that takes the edge off without the sedation, the fog, or the dependence a benzodiazepine leaves you with. The early promise is real and genuinely interesting — here&apos;s what it could do for you, and how far the human proof actually goes.</description><pubDate>Sun, 31 May 2026 14:00:00 GMT</pubDate><content:encoded/></item><item><title>Ipamorelin: the clean growth hormone signal</title><link>https://wolverine.health/articles/ipamorelin-ghrp/</link><guid isPermaLink="true">https://wolverine.health/articles/ipamorelin-ghrp/</guid><description>Ipamorelin asks your own body to release a clean pulse of growth hormone — the recovery, sleep and body-composition signal — without the stress-hormone mess older compounds caused. Here&apos;s what that could mean for you, and how far the human proof actually goes.</description><pubDate>Sun, 31 May 2026 12:30:00 GMT</pubDate><content:encoded/></item><item><title>CJC-1295: turning your own growth hormone back up</title><link>https://wolverine.health/articles/cjc-1295-growth-hormone/</link><guid isPermaLink="true">https://wolverine.health/articles/cjc-1295-growth-hormone/</guid><description>CJC-1295 is engineered to make your own pituitary release growth hormone for days from a single shot — and unusually, a real human trial says it works. Here&apos;s what that could mean for recovery, sleep and body composition, how far the proof goes, and why one name hides two different compounds.</description><pubDate>Sun, 31 May 2026 12:00:00 GMT</pubDate><content:encoded/></item><item><title>Sermorelin: the older growth hormone peptide that still has defenders</title><link>https://wolverine.health/articles/sermorelin-anti-aging/</link><guid isPermaLink="true">https://wolverine.health/articles/sermorelin-anti-aging/</guid><description>Sermorelin is the growth-hormone peptide with a real FDA past — and a clever way of working: it nudges your own gland to make more GH instead of overriding it. Here&apos;s what it could do for you, how far the human proof actually goes, and why its availability isn&apos;t waiting on the July FDA vote.</description><pubDate>Sun, 31 May 2026 11:30:00 GMT</pubDate><content:encoded/></item><item><title>MOTS-c: the exercise signal written into your mitochondria</title><link>https://wolverine.health/articles/mots-c-mitochondria/</link><guid isPermaLink="true">https://wolverine.health/articles/mots-c-mitochondria/</guid><description>MOTS-c is a tiny peptide your mitochondria release when you train — a signal that tells your body to handle fuel and hold onto strength like a younger one. The early science is genuinely exciting. Here is what it could do for you, and how far the human proof actually goes.</description><pubDate>Fri, 29 May 2026 16:00:00 GMT</pubDate><content:encoded/></item><item><title>Selank vs Semax: the calm one and the sharp one</title><link>https://wolverine.health/articles/selank-vs-semax-cognitive/</link><guid isPermaLink="true">https://wolverine.health/articles/selank-vs-semax-cognitive/</guid><description>Selank and Semax get sold side by side as brain peptides, but they solve opposite problems — one calms, one sharpens. Here&apos;s what each could do for you, how far the Russian evidence actually goes, and why the July 2026 FDA review splits them apart.</description><pubDate>Fri, 29 May 2026 16:00:00 GMT</pubDate><content:encoded/></item><item><title>DSIP: the deep-sleep signal your body already makes</title><link>https://wolverine.health/articles/dsip/</link><guid isPermaLink="true">https://wolverine.health/articles/dsip/</guid><description>DSIP (Emideltide on the FDA paperwork) is a peptide your body makes that peaks in your deepest sleep. The idea — hand it back to push deeper sleep and a steadier stress system — is genuinely interesting. Here is what it could do for you, and why the best human trial came back cold.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Epithalon: the four-amino-acid peptide betting it can slow your clock</title><link>https://wolverine.health/articles/epithalon/</link><guid isPermaLink="true">https://wolverine.health/articles/epithalon/</guid><description>Epithalon is the shortest peptide on the longevity menu, built on one bold idea — switching telomerase back on to rebuild the caps on your chromosomes. Here is what it could do for you, how far the proof actually goes, and where it sits on the July 2026 PCAC docket.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Ipamorelin: the clean growth-hormone peptide behind the stack</title><link>https://wolverine.health/articles/ipamorelin/</link><guid isPermaLink="true">https://wolverine.health/articles/ipamorelin/</guid><description>You&apos;ve probably met ipamorelin as the second half of CJC-1295 and ipamorelin. On its own it&apos;s the quieter half — a small peptide built to ask your own body for a clean pulse of growth hormone. Here&apos;s what it could mean for you, why it earned the clean name, and how far the human proof goes.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>MOTS-c: the newest peptide in the longevity conversation</title><link>https://wolverine.health/articles/mots-c/</link><guid isPermaLink="true">https://wolverine.health/articles/mots-c/</guid><description>MOTS-c is a tiny peptide your mitochondria make to help the body handle fuel and hold onto strength — and the level falls with age. Here&apos;s the plain-English tour: what it is, what the early science says it might do, and where the July 2026 FDA review just put it.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>PT-141: the desire switch that works in the brain, not the blood</title><link>https://wolverine.health/articles/pt-141/</link><guid isPermaLink="true">https://wolverine.health/articles/pt-141/</guid><description>PT-141 (bremelanotide) does something the familiar blood-flow pills can&apos;t — it works on desire itself, up in the brain. And it is the rare peptide carrying a real FDA approval and Phase 3 evidence behind it. Here is what it could do for you, and exactly how far that proof actually reaches.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Selank: the anxiety peptide Russia already uses</title><link>https://wolverine.health/articles/selank/</link><guid isPermaLink="true">https://wolverine.health/articles/selank/</guid><description>Selank is a small peptide Russia has used for anxiety since 2009 — calm without the benzodiazepine baggage, built from a fragment your immune system already makes. Here is what it is, what it might do, how good the evidence really is, and where it stands with US regulators.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Semax: the brain-protection peptide Russia has used for thirty years</title><link>https://wolverine.health/articles/semax/</link><guid isPermaLink="true">https://wolverine.health/articles/semax/</guid><description>Semax is a Russian brain peptide with an unusual credential — three decades of real clinical use in stroke care, not just a biohacker rumour. Here is what it could do across neuroprotection and focus, how far the proof runs, and its spot on the FDA&apos;s July 2026 PCAC docket.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Sermorelin: the growth-hormone peptide that was a real FDA drug — twice</title><link>https://wolverine.health/articles/sermorelin/</link><guid isPermaLink="true">https://wolverine.health/articles/sermorelin/</guid><description>Sermorelin is the rare longevity peptide with an actual FDA past: sold as Geref, first as a diagnostic and then as a treatment for kids who couldn&apos;t make enough growth hormone. Here&apos;s what it is, what the human evidence covers, and where it sits with the FDA and WADA now.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Tesamorelin: the GHRH peptide with a real FDA approval behind it</title><link>https://wolverine.health/articles/tesamorelin/</link><guid isPermaLink="true">https://wolverine.health/articles/tesamorelin/</guid><description>Tesamorelin is the rare peptide that went through a Phase 3 trial and came out an approved drug — and what it targets is the deep, dangerous belly fat. Here is what it could do for you, and exactly where the approved evidence stops and off-label hope begins.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>Thymosin Alpha-1: the immune peptide with a real drug record</title><link>https://wolverine.health/articles/thymosin-alpha-1/</link><guid isPermaLink="true">https://wolverine.health/articles/thymosin-alpha-1/</guid><description>Thymosin Alpha-1 is the rare peptide that is already an approved drug in dozens of countries — a signal your thymus makes to run your immune system, and makes less of as you age. Here is what it could do for you, the range of what it has been used for, and where the US regulation actually stands.</description><pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate><content:encoded/></item><item><title>CJC-1295: One 2006 Study, Eighteen Years of Weekly Use</title><link>https://wolverine.health/articles/cjc-1295/</link><guid isPermaLink="true">https://wolverine.health/articles/cjc-1295/</guid><description>CJC-1295 reliably raises GH and IGF-1 in humans, confirmed by a single 2006 pharmacokinetic study. Whether that translates into any functional benefit has never been tested.</description><pubDate>Thu, 12 Jun 2025 09:00:00 GMT</pubDate><content:encoded/></item></channel></rss>